Ocrelizumab, klinická aktivita a progrese – dlouhodobá data // SOLEN

Neurológia pre prax 3/2019

Ocrelizumab, clinical aktivity and progression – long-term data

Multiple sclerosis is a chronic inflammatory demyelinating disease which affect central nervous system. Treatment options in multiple sclerosis have expanded considerably in the recent years. This article deals with new data about clinical activity, influencing of disease progresion among patients treated with ocrelizumab.

Keywords: multiple sclerosis, ocrelizumab, CDP, PIRA, RAW